37
Participants
Start Date
August 3, 2012
Primary Completion Date
November 29, 2018
Study Completion Date
September 1, 2020
Pharmacological Study
Correlative studies
Romidepsin
Given IV
Thomas Jefferson University Hospital, Philadelphia
National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Emory University Hospital/Winship Cancer Institute, Atlanta
Case Western Reserve University, Cleveland
Wayne State University/Karmanos Cancer Institute, Detroit
Mayo Clinic in Rochester, Rochester
University of Chicago Comprehensive Cancer Center, Chicago
City of Hope Comprehensive Cancer Center, Duarte
University of California Davis Comprehensive Cancer Center, Sacramento
Penn State Milton S Hershey Medical Center, Hershey
University Health Network-Princess Margaret Hospital, Toronto
Collaborators (1)
Celgene Corporation
INDUSTRY
National Cancer Institute (NCI)
NIH